comparemela.com
  1. Home
  2. Live Updates
  3. Onxeo Stock Exchange - Breaking News

Page 2 - Onxeo Stock Exchange News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Onxeo : to present new preclinical data highlighting AsiDNA™ s ability to fight tumor resistance and protect from anticancer treatment toxicity at AACR Annual Meeting 2022

AsiDNA™ proven to overcome resistance to tyrosine kinase inhibitors in lung cancer models AsiDNA™ proven to protect healthy cells when combined with. | March 31, 2022

United statesFrance generalWael jdeyOnxeo sa euronextMarie dutreix institut curieAmerican association for cancer research annual meetingGilles favre cancer research centerEuronext growth parisFirst north copenhagenAmerican associationCancer research annual meetingGilles favreCancer research centerMarie dutreixInstitut curiePreclinical lead

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.